Ensysce Biosciences submits Phase 3 protocol to FDA
PremiumThe FlyEnsysce Biosciences submits Phase 3 protocol to FDA
24d ago
Ensysce Biosciences posts video updates from IASP World Congress on Pain
Premium
The Fly
Ensysce Biosciences posts video updates from IASP World Congress on Pain
30d ago
3 Penny Stocks to Watch Now, 8/29/24
Premium
Market News
3 Penny Stocks to Watch Now, 8/29/24
1M ago
Ensysce Biosciences hosts IASP 2024 Symposium
PremiumThe FlyEnsysce Biosciences hosts IASP 2024 Symposium
3M ago
Ensysce Biosciences discusses key themes from EPHMRA 2024
Premium
The Fly
Ensysce Biosciences discusses key themes from EPHMRA 2024
4M ago
Ensysce Biosciences announces partnership with Purisys for PF9001
Premium
The Fly
Ensysce Biosciences announces partnership with Purisys for PF9001
4M ago
Ensysce Biosciences to hold a corporate update conference call
PremiumThe FlyEnsysce Biosciences to hold a corporate update conference call
7M ago
Ensysce Biosciences reports Q4 EPS ($1.13) vs. ($18.30) last year
Premium
The Fly
Ensysce Biosciences reports Q4 EPS ($1.13) vs. ($18.30) last year
7M ago
Ensysce Biosciences receives positive Nasdaq listing determination
Premium
The Fly
Ensysce Biosciences receives positive Nasdaq listing determination
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100